secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K/A
Filed at:   2024-05-16T23:59:59+00:00
Accession:  0001213900-24-044136
Event type: other_material
Sentiment:  neutral
Materiality: 0.85
Item codes: 3.03, 5.03
LLM model:  deepseek-v4-flash:cloud@v2

Heart Test Laboratories files 8-K/A to clarify reverse stock split and warrant adjustments
--------------------------------------------------------------------------------

- Heart Test Laboratories filed Amendment No. 1 to Form 8-K to clarify details of its 1-for-100 reverse stock split.
- The reverse stock split affects both common stock and warrants, with split-adjusted trading expected at market open on May 17, 2024.
- The exercise price of public warrants will be proportionately increased to $425.00 per share post-split.
- The CUSIP for common stock changes to 42254E302; trading symbols HSCS and HSCSW remain unchanged.
- Equitable adjustments to outstanding warrants ensure every 100 pre-split shares become 1 post-split share upon exercise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000121390024044136/0001213900-24-044136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000121390024044136/ea0206327-8ka1_heart.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-044136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer